2020 意大利临床实践指南:胆管癌-第1部分:分类,诊断和分期

2020-09-03 意大利肝病学会 Dig Liver Dis . 2020 Sep 3;

胆管癌是第2位常见的原发性肝癌,以预后差和化疗耐药为特点。在过去的20年间,全世界范围内胆管癌的发病率和死亡率逐渐增加。本文为意大利肝脏研究协会与其他学会组织合作共同制定,作为该指南的第1部分内容,主

中文标题:

2020 意大利临床实践指南:胆管癌-第1部分:分类,诊断和分期

英文标题:

Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging

发布机构:

意大利肝病学会

发布日期:

2020-09-03

简要介绍:

胆管癌是第2位常见的原发性肝癌,以预后差和化疗耐药为特点。在过去的20年间,全世界范围内胆管癌的发病率和死亡率逐渐增加。本文为意大利肝脏研究协会与其他学会组织合作共同制定,作为该指南的第1部分内容,主要涉及胆管癌的分类,诊断和分期。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 意大利临床实践指南:胆管癌-第1部分:分类,诊断和分期.pdf)] GetToolGuiderByIdResponse(projectId=1, id=961d51c0019e30dd, title=2020 意大利临床实践指南:胆管癌-第1部分:分类,诊断和分期, enTitle=Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging, guiderFrom=Dig Liver Dis . 2020 Sep 3;, authorId=0, author=, summary=胆管癌是第2位常见的原发性肝癌,以预后差和化疗耐药为特点。在过去的20年间,全世界范围内胆管癌的发病率和死亡率逐渐增加。本文为意大利肝脏研究协会与其他学会组织合作共同制定,作为该指南的第1部分内容,主, cover=https://img.medsci.cn/2020920/1600613366956_2020535.jpg, journalId=0, articlesId=null, associationId=487, associationName=意大利肝病学会, associationIntro=意大利肝病学会致力于肝病研究,官方杂志《Digestive and Liver Disease》, copyright=0, guiderPublishedTime=Thu Sep 03 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>胆管癌是第2位常见的原发性肝癌,以预后差和化疗耐药为特点。在过去的20年间,全世界范围内胆管癌的发病率和死亡率逐渐增加。本文为意大利肝脏研究协会与其他学会组织合作共同制定,作为该指南的第1部分内容,主要涉及胆管癌的分类,诊断和分期。</p> </div> </div> </div>, tagList=[TagDto(tagId=2872, tagName=胆管癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2872, guiderKeyword=胆管癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2743, appHits=184, showAppHits=0, pcHits=754, showPcHits=2558, likes=3, shares=5, comments=11, approvalStatus=1, publishedTime=Sun Sep 20 23:45:29 CST 2020, publishedTimeString=2020-09-03, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Sep 20 22:49:31 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 03:24:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 意大利临床实践指南:胆管癌-第1部分:分类,诊断和分期.pdf)])
2020 意大利临床实践指南:胆管癌-第1部分:分类,诊断和分期.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1228239, encodeId=0a8e122823956, content=指南很有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:06 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056463, encodeId=f9381056463cd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c595609897, createdName=ms5000001043430616, createdTime=Thu Sep 30 12:54:51 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007202, encodeId=c6ed100e2023a, content=学习了!!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210208/c3dc2580e0ac4c8191eae47c717138a5/1e85aea19cb54b3da3746e58584795cf.jpg, createdBy=a3975411105, createdName=Half, createdTime=Thu Aug 12 09:24:54 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926587, encodeId=a0e892658ecc, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb685450564, createdName=ms4000001559469367, createdTime=Tue Feb 23 13:53:27 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926770, encodeId=29cc926e70c4, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:34:36 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2022-06-23 145d4c03m99暂无昵称

    指南很有指导意义

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1228239, encodeId=0a8e122823956, content=指南很有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:06 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056463, encodeId=f9381056463cd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c595609897, createdName=ms5000001043430616, createdTime=Thu Sep 30 12:54:51 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007202, encodeId=c6ed100e2023a, content=学习了!!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210208/c3dc2580e0ac4c8191eae47c717138a5/1e85aea19cb54b3da3746e58584795cf.jpg, createdBy=a3975411105, createdName=Half, createdTime=Thu Aug 12 09:24:54 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926587, encodeId=a0e892658ecc, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb685450564, createdName=ms4000001559469367, createdTime=Tue Feb 23 13:53:27 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926770, encodeId=29cc926e70c4, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:34:36 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2021-09-30 ms5000001043430616

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1228239, encodeId=0a8e122823956, content=指南很有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:06 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056463, encodeId=f9381056463cd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c595609897, createdName=ms5000001043430616, createdTime=Thu Sep 30 12:54:51 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007202, encodeId=c6ed100e2023a, content=学习了!!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210208/c3dc2580e0ac4c8191eae47c717138a5/1e85aea19cb54b3da3746e58584795cf.jpg, createdBy=a3975411105, createdName=Half, createdTime=Thu Aug 12 09:24:54 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926587, encodeId=a0e892658ecc, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb685450564, createdName=ms4000001559469367, createdTime=Tue Feb 23 13:53:27 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926770, encodeId=29cc926e70c4, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:34:36 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2021-08-12 Half

    学习了!!!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1228239, encodeId=0a8e122823956, content=指南很有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:06 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056463, encodeId=f9381056463cd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c595609897, createdName=ms5000001043430616, createdTime=Thu Sep 30 12:54:51 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007202, encodeId=c6ed100e2023a, content=学习了!!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210208/c3dc2580e0ac4c8191eae47c717138a5/1e85aea19cb54b3da3746e58584795cf.jpg, createdBy=a3975411105, createdName=Half, createdTime=Thu Aug 12 09:24:54 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926587, encodeId=a0e892658ecc, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb685450564, createdName=ms4000001559469367, createdTime=Tue Feb 23 13:53:27 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926770, encodeId=29cc926e70c4, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:34:36 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2021-02-23 ms4000001559469367

    积分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1228239, encodeId=0a8e122823956, content=指南很有指导意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7d25091682, createdName=145d4c03m99暂无昵称, createdTime=Thu Jun 23 16:33:06 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056463, encodeId=f9381056463cd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c595609897, createdName=ms5000001043430616, createdTime=Thu Sep 30 12:54:51 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007202, encodeId=c6ed100e2023a, content=学习了!!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210208/c3dc2580e0ac4c8191eae47c717138a5/1e85aea19cb54b3da3746e58584795cf.jpg, createdBy=a3975411105, createdName=Half, createdTime=Thu Aug 12 09:24:54 CST 2021, time=2021-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926587, encodeId=a0e892658ecc, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb685450564, createdName=ms4000001559469367, createdTime=Tue Feb 23 13:53:27 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926770, encodeId=29cc926e70c4, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 08:34:36 CST 2021, time=2021-02-24, status=1, ipAttribution=)]
    2021-02-24

    👍

    0